The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Evicel Market During 2026–2030?

Historically, expansion was linked to elevated intraoperative bleeding risks, the constraints of mechanical hemostasis, the increasing use of plasma-derived products, a rise in complex surgical procedures, and an emphasis on ensuring patient safety.

The anticipated expansion during the forecast period is fueled by an uptick in minimally invasive surgical procedures, an increase in overall surgical caseloads, the proliferation of specialized medical centers, breakthroughs in surgical biomaterials, and a greater emphasis on enhancing surgical efficiency. Concurrently, significant developments expected over the forecast horizon encompass the increasing application of fibrin sealants in operations, a surging requirement for biocompatible hemostatic agents, a rise in cardiovascular and liver surgical interventions, a preference for sealants derived from human plasma, and the broader adoption of advanced surgical methods.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20068&type=smp

What Primary Factors Are Fueling The Expansion Of The Evicel Market?

An increasing occurrence of bleeding disorders is projected to boost the expansion of the evicel market. These conditions are health issues where blood fails to clot adequately, resulting in excessive or extended bleeding following trauma or operations. The growing incidence of bleeding disorders stems from multiple causes, including an uptick in inherited conditions like hemophilia, lifestyle choices such as inadequate nutrition and excess weight, and the increasing presence of long-term illnesses like liver disorders, which impair the body’s clotting capability. Evicel serves as a fibrin sealant in cases of blood disorders to aid in stopping bleeding during operations. It shows notable efficacy in managing hemorrhage in individuals facing clotting difficulties, such as those with hemophilia or other deficiencies in coagulation. For instance, in May 2025, according to Pfizer Inc., a US-based biopharmaceutical corporation, in the UK, the haemophilia A and B patient population exceeded 11,800 individuals in the 2023/2024 period. Consequently, the increasing prevalence of bleeding disorders is set to propel the expansion of the evicel market.

What Segment Categories Are Evaluated In The Evicel Market Study?

The evicel market covered in this report is segmented –

1) By Type of Surgery: Orthopedic Surgeries, Cardiac Surgeries, General Surgeries, Liver Surgeries, Gynecological Surgeries

2) By Distribution Channel: Hospital Pharmacies, Surgical Supply Distributors, Outpatient Surgery Centers

3) By End-User: Hospitals, Specialty Clinics, Other End-Users

Who Are The Leading Firms Participating In The Evicel Market?

Major companies operating in the evicel market are Johnson & Johnson (Omrix Biopharmaceuticals Ltd)

Access The Complete Evicel Market Report:

https://www.thebusinessresearchcompany.com/report/evicel-global-market-report

Which Regional Market Leads The Evicel Market?

North America was the largest region in the evicel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the evicel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.